Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: OHI stock price vs PLD: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PLD's multiple
Needs PLD P/E.
Implied fair value · at OHI's multiple
Needs OHI P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
OMEGA HEALTHCARE INVESTORS, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Prologis, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
WELLTOWER INC.
OHI vs WELL
Ventas, Inc.
OHI vs VTR
Sabra Health Care REIT, Inc.
OHI vs SBRA
LTC PROPERTIES INC
OHI vs LTC
HEALTHPEAK PROPERTIES, INC.
OHI vs DOC
STAG Industrial, Inc.
OHI vs STAG
EASTGROUP PROPERTIES INC
OHI vs EGP
WEYERHAEUSER CO
OHI vs WY
COSTAR GROUP, INC.
OHI vs CSGP
UDR, Inc.
OHI vs UDR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe OHI's faster growth and stronger margin profile can sustain without a higher leverage penalty, then OHI looks reasonable to own versus PLD because it trades at lower P/E and EV/EBITDA multiples; if leverage and capital efficiency matter more, the discount may be justified.
OHI trades at a lower P/E and EV/EBITDA than PLD, suggesting it is cheaper on current earnings and cash-flow proxy measures. However, the implied price of $76.38 sits well above OHI's current price of $48.46, while the broader valuation context is mixed because EV/Revenue is nearly identical between the two.
Supporting Metrics
